A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...
One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...
Zacks Small Cap Research on MSN1d
EVAX Ups Cash to Further ResearchEVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...
Harnessing digital pathology to inform personalized immunotherapies on the forefront of veterinary medicineFARMINGTON, Conn. and PHILADELPHIA, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Torigen Pharmaceuticals ...
The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
Harnessing AI to Revolutionize Vaccine and Therapy Development ATLANTA, GA - (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX ...
WASHINGTON – Facing intense scrutiny from senators over his potential profit from vaccine lawsuits while serving as the ...
The man who hopes to be President Donald Trump’s health secretary says he needs to see data showing vaccines are safe, but he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback